Modeling the impact of delaying surgery for early esophageal cancer in the era of COVID‑19

Surgical society guidelines have recommended changing the treatment strategy for early esophageal cancer during the novel coronavirus (COVID-19) pandemic. Delaying resection can allow for interim disease progression, but the impact of this delay on mortality is unknown. The COVID-19 infection rate at which immediate operative risk exceeds benefit is unknown. We sought to model immediate versus delayed surgical resection in a T1b esophageal adenocarcinoma.

Modeling the impact of delaying surgery for early esophageal cancer in the era of COVID‑19
Size: 1.2 MB